Transplant hope for diabetes patients

From this month, six centres across the UK will enable selected people with Type 1 diabetes to live free from blackouts and hospital admissions associated with hypoglycaemia. The Department of Health has announced that it will invest up to £2.34 million in islet transplant services in the first year, increasing to a maximum of £7.32 m to meet the predicted annual need in the longer term.

People receiving the treatment will be injected with insulin producing islets, taken from a donated pancreas. In the first year, it is expected that around 20 transplants will take place at the Oxford Radcliffe Hospitals NHS Trust, the Royal Free Hampstead NHS Trust, London, Kings College Hospital NHS Foundation Trust, London, Newcastle-upon-Tyne Hospitals NHS Trust, North Bristol NHS Trust and Central Manchester and Manchester Children’s NHS Trust. The service will then expand to meet the predicted annual need of approximately 80 transplants in subsequent years.

Islet transplantation is a suitable alternative to whole organ pancreas transplant as it is less invasive and can be considered for patients with cardiac disease who would be unfit for open surgery. Transplants have previously been offered to 12 patients in England under funding from charities, principally Diabetes UK.

Latest Issues

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

IGPP Annual Operating Theatres Show

Manchester, Etihad Stadium
11th September 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025